Seroprevalence of hepatitis b markers in pregnant women in Kenya

East African Medical Journal

Volumn 83, Issue 9, 2006, Pages 485-493

  Okoth, F ^a   Mbuthia, J ^b   Gatheru, Z ^b   Murila, F ^b   Kanyingi, F ^b   Mugo, F ^b   Esamai, F ^b   Alavi, Z ^b   Otieno, J ^b   Kiambati, H ^c   Wanjuki, N ^d  

^a KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^b Kenya Paediatric Association   (Kenya)

^c Isiolo District Hospital

^d MINISTRY OF HEALTH   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN;

ADOLESCENT; ADULT; ARTICLE; BLOOD; CHILD; EPIDEMIOLOGY; FEMALE; HEPATITIS B; HUMAN; KENYA; PREGNANCY; PREGNANCY COMPLICATION;

ADOLESCENT; ADULT; BIOLOGICAL MARKERS; CHILD; FEMALE; HEPATITIS B; HEPATITIS B E ANTIGENS; HEPATITIS B SURFACE ANTIGENS; HUMANS; KENYA; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SEROEPIDEMIOLOGIC STUDIES;

EID: 34249854823     PISSN: 0012835X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (17)

1. Kane M. Global programme for the control of hepatitis B infection. Vaccine. 1995; 13(Supp.): S47-S49
2. Edmunds W.J., Medley G.F., Noke D.J., et al. Epidemiological patterns of hepatitis B virus in highly endemic areas. Epidemiol. Infections. 1996; 117:313-325.
3. Greenfield C., Osidiana V., Karayiannis P., et al. Perinatal transmission of hepatitis B virus in Kenya: It's relation to the presence of serum HBV-DNA and anti-HBe in the mother. J. Med. Virol. 1986; 19:135-142.
4. Schafer D.F. and Sorrell M.F. Hepatocellular Carcinoma. Lancet. 1999; 353:1253-1257.
5. Stevens C.E., Beasley R.P., Tsui J. and Lee W.C. Vertical transmission of hepatitis B antigen in Taiwan. New Engl. J. Med. 1975; 292:771.
6. Okoth F.A., Kobayashi M., Kaptich D.C., et al. Seroepidemiological study for HBV markers and antiDelta in Kenya. East Afr. Med. J. 1991; 68:515-525.
7. Wankya B.M., Hansen D.P., Ngindu A.M.N., Feinstone S.F. and Purcell R.H. Seroepidemiology of hepatitis A and B in Kenya: A rural population survey in Machakos district. East Afr. Med. J. 1979; 56:134-138.
8. Hyams K.C., Okoth F.A., Tukei P.M., et al. Epidemiology of hepatitis B in Eastern Kenya. J. Med. Virol. 1989; 28:106-109.
9. Bowry T.R., Pade J., Omari M. and Chemtai A. A pilot study of hepatitis B virus. Seroepidemiology suggests widespread immunosuppression in the nomadic inhabitants of Turkana District of Kenya. East Afr. Med. J. 1985; 62:501-506.
10. Okoth F.A., Yamanaka T., Takayanagi N., et al. A community based longitudinal study of viral hepatitis B in a rural community. East Afr. Med. J. 1990; 67:640-649.
11. Chang M.H., Chen C.J., Lai M.S., et al. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. Taiwan Childhood Hepatoma Study Group. New Engl. J. Med. 1997; 336:1855-1859.
12. Okoth F.A., Kobayashi M., Takayanagi N., et al. Efficacy of hepatitis B vaccine in a rural community in Muranga, Kenya. East Afr. Med. J. 1994; 71:250-252.
13. Zanetti A.R., Ferroni P., Magliano E.M., et al. Perinatal transmission of the hepatitis B virus and Delta-agent from mother-to-offspring in northern Italy. J. Med. Virol. 1982; 9:139-148.
14. Expanded Programme on Immunisation. Global programme for vaccine and immunisation. 1996. WHO Geneva.
15. Newcombe R.G. Two-sided confidence intervals for the single proportion: Comparison of seven methods, Statistics Med. 1998; 17:857-872.
16. Chauvin P., Ekra D. and Plotkin S.A. The cost of not implementing routine neonates immunisation programme in HbsAg high prevalent countries. Vaccine. 2002; 20:2848-2850.
17. WHO/V&B 131 Nov. 2001 Geneva, Switzerland.